Generation Bio

Generation Bio

Generation Bio

Generation Bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have druglike properties, including ability to titrate to effect and redose.
Type
B2c
Founded
2016
Raised
$100M
Follow us
Alexa global traffic share
Latest funding
$100,000,000
Venture capital (Series B) - 2018
Deerfield Management Company Foresite Capital Invus +3
Team Size
10+
Employees
Xconomy

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

FinSMEs

Generation Bio Raises $110M in Series C Financing

$100,000,000 Venture capital (Series B)
FinSMEs

Generation Bio Raises $100M in Series B Financing

Funding Health Science